Detalhe da pesquisa
1.
Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinib.
Cancer Immunol Immunother;
72(6): 1661-1672, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36602564
2.
Synergistic lethality in chronic myeloid leukemia - targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatment.
BMC Cancer;
23(1): 1153, 2023 Nov 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38012567
3.
The small chain fatty acid butyrate antagonizes the TCR-stimulation-induced metabolic shift in murine epidermal gamma delta T cells.
EXCLI J;
19: 334-350, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32256272